L ista de publicaciones realizadas en colaboración con la Unidad de Investigación de la AEDV:

Biobadaderm y Psonet:

  • Possible paradoxical occurrence of inflammatory arthritis in patients with psoriasis treated with biologics: findings in the Biobadaderm cohort. Ruiz-Genao D, Perez-Zafrilla B, Lopez-Estebaranz JL, Belinchon-Romero I, Carrascosa JM, Ferran M, Vanaclocha F, Herrera-Ceballos E, Garcia-Doval I, Biobadaderm Study G. Br J Dermatol 2016.
  • Development of clinical prediction models for good or bad response to classic systemic drugs, anti-TNFs, and ustekinumab in psoriasis, based on the BIOBADADERM cohort. Garcia-Doval I, Perez-Zafrilla B, Ferrandiz C, Carretero G, Dauden E, de la Cueva P, Gomez-Garcia FJ, Herrera-Ceballos E, Belinchon-Romero I, Sanchez-Carazo JL, Lopez-Estebaranz JL, Alsina M, Ferran M, Torrado R, Carrascosa JM, Rivera R, Vanaclocha F, Group BS. J Dermatolog Treat 2016; 27: 203-9.
  • Should tumour necrosis factor antagonist safety information be applied from patients with rheumatoid arthritis to psoriasis? Rates of serious adverse events in the prospective rheumatoid arthritis BIOBADASER and psoriasis BIOBADADERM cohorts. Garcia-Doval I, Hernandez MV, Vanaclocha F, Sellas A, de la Cueva P, Montero D, Biobadaderm, groups Bs. Br J Dermatol 2016.
  • Risk of serious infections, cutaneous bacterial infections, and granulomatous infections in patients with psoriasis treated with anti-tumor necrosis factor agents versus classic therapies: Prospective meta-analysis of Psonet registries. Garcia-Doval I, Cohen AD, Cazzaniga S, Feldhamer I, Addis A, Carretero G, Ferrandiz C, Stern RS, Naldi L, Psonet N. J Am Acad Dermatol 2016.
  • Management of biologic therapy in moderate to severe psoriasis in surgical patients: Data from the Spanish Biobadaderm Registry. Galiano Mejias S, Carretero G, Ferrandiz C, Vanaclocha F, Dauden E, Gomez-Garcia FJ, Herrera-Ceballos E, Belinchon-Romero I, Sanchez-Carazo JL, Lopez-Estebaranz JL, Alsina M, Ferran M, Torrado R, Carrascosa JM, Rivera R, Llamas-Velasco M, Jimenez-Puya R, Mendiola MV, Ruiz-Genao D, Descalzo MA, de la Cueva Dobao P, del grupo B. Actas Dermosifiliogr 2016.
  • A Case Series of Patients With Psoriasis Exposed to Biologic Therapy During Pregnancy: The BIOBADADERM Register and a Review of the Literature. Echeverria-Garcia B, Nuno-Gonzalez A, Dauden E, Vanaclocha F, Torrado R, Belinchon I, Perez-Zafrilla B, Grupo de estudio B. Actas Dermosifiliogr 2016.
  • Factors Associated with Receiving Biologics or Classic Systemic Therapy for Moderate-to-Severe Psoriasis: Evidence from the PSONET Registries. Davila-Seijo P, Garcia-Doval I, Naldi L, Cazzaniga S, Augustin M, Rustenbach SJ, Dauden E, Dam TN, Baker C, Spuls PI, Stern RS, Cohen AD. Acta Derm Venereol 2016.
  • Drug Survival Analysis Is Not a Good Method for Assessing the Safety or Effectiveness of Systemic Therapies in Psoriasis. Davila-Seijo P, Garcia-Doval I. Actas Dermosifiliogr 2016.
  • Infections in Moderate to Severe Psoriasis Patients Treated with Biological Drugs Compared to Classic Systemic Drugs: Findings from the BIOBADADERM Registry. Davila-Seijo P, Dauden E, Descalzo MA, Carretero G, Carrascosa JM, Vanaclocha F, Gomez-Garcia FJ, De la Cueva-Dobao P, Herrera-Ceballos E, Belinchon I, Lopez-Estebaranz JL, Alsina M, Sanchez-Carazo JL, Ferran M, Torrado R, Ferrandiz C, Rivera R, Llamas M, Jimenez-Puya R, Garcia-Doval I, Group BS. J Invest Dermatol 2016.
  • Survival of classic and biological systemic drugs in psoriasis: results of the BIOBADADERM registry and critical analysis. Davila-Seijo P, Dauden E, Carretero G, Ferrandiz C, Vanaclocha F, Gomez-Garcia FJ, Herrera-Ceballos E, De la Cueva-Dobao P, Belinchon I, Sanchez-Carazo JL, Alsina M, Lopez-Estebaranz JL, Ferran M, Torrado R, Carrascosa JM, Llamas M, Rivera R, Jimenez-Puya R, Garcia-Doval I, Group BS. J Eur Acad Dermatol Venereol 2016; 30: 1942-50.
  • Risk of Reactivation of Hepatitis B Virus Infection in Psoriasis Patients Treated With Biologics: A Retrospective Analysis of 20 Cases From the BIOBADADERM Database. Sanz-Bueno J, Vanaclocha F, Garcia-Doval I, Torrado R, Carretero G, Dauden E, Patricia Ruiz-Genao D, Alsina-Gibert MM, Perez-Zafrilla B, Perez-Rial G, Rivera R, members of the Bg. Actas Dermosifiliogr 2015; 106: 477-82.
  • Safety of classic and biologic systemic therapies for the treatment of psoriasis in elderly: an observational study from national BIOBADADERM registry. Medina C, Carretero G, Ferrandiz C, Dauden E, Vanaclocha F, Gomez-Garcia FJ, Herrera-Ceballos E, De la Cueva-Dobao P, Belinchon I, Sanchez-Carazo JL, Alsina M, Lopez-Estebaranz JL, Ferran M, Carrascosa JM, Torrado R, Argila D, Rivera R, Jimenez-Puya R, Garcia-Doval I, Group BS. J Eur Acad Dermatol Venereol 2015; 29: 858-64.
  • Risk of adverse events in psoriasis patients receiving classic systemic drugs and biologics in a 5-year observational study of clinical practice: 2008-2013 results of the Biobadaderm registry. Carretero G, Ferrandiz C, Dauden E, Vanaclocha Sebastian F, Gomez-Garcia FJ, Herrera-Ceballos E, De la Cueva-Dobao P, Belinchon I, Sanchez-Carazo JL, Alsina-Gibert M, Lopez-Estebaranz JL, Ferran M, Torrado R, Carrascosa JM, Carazo C, Rivera R, Jimenez-Puya R, Garcia-Doval I, Group BS. J Eur Acad Dermatol Venereol 2015; 29: 156-63.
  • Does the treatment ladder for systemic therapy in moderate to severe psoriasis only go up? The percentage of patients with severe psoriasis on biologics increases over time. Carrascosa JM, Rivera N, Garcia-Doval I, Carretero G, Vanaclocha F, Dauden E, Gomez-Garcia FJ, De-la-Cueva-Dobao P, Herrera-Ceballos E, Belinchon I, Alsina M, Sanchez-Carazo JL, Ferran M, Lopez-Estebaranz JL, Perez-Zafrilla B, Llamas M, Rivera R, Ferrandiz C, Group BS. Actas Dermosifiliogr 2015; 106: 638-43.
  • Use of off-label doses is frequent in biologic therapy for moderate to severe psoriasis: A cross-sectional study in clinical practice. Carrascosa JM, Garcia-Doval I, Perez-Zafrilla B, Carretero G, Vanaclocha F, Dauden E, De la Cueva-Dobao P, Belinchon I, Alsina M, Lopez-Estebaranz JL, Ferran M, Torrado R, Rivera R, Carazo C, Barboza L, Ferrandiz C, Group BS. J Dermatolog Treat 2015; 26: 502-6.
  • Body mass index in patients with moderate-to-severe psoriasis in Spain and its impact as an independent risk factor for therapy withdrawal: results of the Biobadaderm Registry. Carrascosa JM, Vilavella M, Garcia-Doval I, Carretero G, Vanaclocha F, Dauden E, Gomez-Garcia FJ, Herrera-Ceballos E, De la Cueva Dobao P, Belinchon I, Sanchez-Carazo JL, Alsina M, Lopez-Estebaranz JL, Ferran M, Peral F, Torrado R, Rivera R, Jimenez-Puya R, Mendiola MV, Ferrandiz C, Group BS. J Eur Acad Dermatol Venereol 2014; 28: 907-14.
  • Latent tuberculosis infection and active tuberculosis in patients with psoriasis: a study on the incidence of tuberculosis and the prevalence of latent tuberculosis disease in patients with moderate-severe psoriasis in Spain. BIOBADADERM registry. Sanchez-Moya AI, Garcia-Doval I, Carretero G, Sanchez-Carazo J, Ferrandiz C, Herrera Ceballos E, Alsina M, Ferran M, Lopez-Estebaranz JL, Gomez-Garcia F, De la Cueva Dobao P, Carrascosa JM, Vanaclocha F, Belinchon I, Peral F, Dauden E, Group BS. J Eur Acad Dermatol Venereol 2013; 27: 1366-74.
  • Systemic psoriasis therapy shows high between-country variation: a sign of unwarranted variation? Cross-sectional analysis of baseline data from the PSONET registries. Garcia-Doval I, Rustenbach SJ, Stern R, Dam TN, Cohen AD, Baker C, Spuls PI, Naldi L, Psonet N. Br J Dermatol 2013; 169: 710-4.
  • Risk of serious adverse events associated with biologic and nonbiologic psoriasis systemic therapy: patients ineligible vs eligible for randomized controlled trials. Garcia-Doval I, Carretero G, Vanaclocha F, Ferrandiz C, Dauden E, Sanchez-Carazo JL, Alsina M, Herrera-Ceballos E, Gomez-Garcia FJ, Ferran M, Lopez-Estebaranz JL, Hernanz JM, Belinchon-Romero I, Vilar-Alejo J, Rivera R, Carrascosa JM, Carazo C. Arch Dermatol 2012; 148: 463-70.
  • [BIOBADADERM, the Spanish Registry of Adverse Events Associated with Biologic Drugs in Dermatology: first report]. Rivera R, Garcia-Doval I, Carretero G, Dauden E, Sanchez-Carazo J, Ferrandiz C, Herrera E, Alsina M, Ferran M, Lopez-Estebaranz JL, Gomez F, Herranz JM, Carrascosa JM, Vanaclocha F, miembros del grupo B. Actas Dermosifiliogr 2011; 102: 132-41.

Registro de cirugía de Mohs (REGESMOHS):

  • Census of Centers That Perform Mohs' Micrographic Surgery in Spain and Description of Their Activity: A Feasibility Study for the Mohs' Micrographic Surgery Registry of the Foundation of the Spanish Academy of Dermatology and Venereology. Alonso-Alonso T, Redondo-Bellon P, Sanmartin-Jimenez O, de Eusebio-Murillo E, Garcia-Doval I, Rodriguez-Prieto MA. Actas Dermosifiliogr 2015; 106: 764-6.
  • Description of Patients Undergoing Mohs Surgery in Spain: Initial Report on Data From the Spanish Registry of Mohs Surgery (REGESMOHS). Ruiz-Salas V, Garces JR, Minano Medrano R, Alonso-Alonso T, Rodriguez-Prieto MA, Lopez-Estebaranz JL, Sanmartin-Jimenez O, Guillen Barona C, Delgado Jimenez Y, Toll-Abello A, Vargas Diez E, Ciudad.
  • Blanco C, Alfaro Rubio A, Allende Markixana I, de Eusebio Murillo E, Manubens-Mercade E, Vazquez-Veiga H, Barchino Ortiz L, Garcia-Doval I, Redondo Bellon P. Actas Dermosifiliogr 2015; 106: 562-8.

Revisiones sistemáticas:

  • A systematic review of clinical trials of treatments for the congenital ichthyoses, excluding ichthyosis vulgaris. Hernandez-Martin A, Aranegui B, Martin-Santiago A, Garcia-Doval I. J Am Acad Dermatol 2013; 69: 544-9 e8.
  • Phototherapy in atopic dermatitis: a systematic review of the literature. Perez-Ferriols A, Aranegui B, Pujol-Montcusi JA, Martin-Gorgojo A, Campos-Dominguez M, Feltes RA, Gilaberte Y, Echeverria-Garcia B, Alvarez-Perez A, Garcia-Doval I. Actas Dermosifiliogr 2015; 106: 387-401.
  • Skin Cancer Incidence and Mortality in Spain: A Systematic Review and Meta-Analysis. Tejera-Vaquerizo A, Descalzo-Gallego MA, Otero-Rivas MM, Posada-Garcia C, Rodriguez-Pazos L, Pastushenko I, Marcos-Gragera R, Garcia-Doval I. Actas Dermosifiliogr 2016; 107: 318-28.

Otros:

  • Methyl aminolevulinate photodynamic therapy for onychomycosis: a multicentre, randomized, controlled clinical trial. Gilaberte Y, Robres MP, Frias MP, Garcia-Doval I, Rezusta A, Aspiroz C. J Eur Acad Dermatol Venereol 2016.
  • Fragmented Health Care Delivery in Ichthyosis. Hernandez-Martin A, Davila'Seijo P, Soria de Francisco JM, Arroyo-Manzanal MI, Garcia-Doval I. Actas Dermosifiliogr 2015; 106: 514-5.
  • Prioritization of therapy uncertainties in congenital ichthyosis: results from a Priority Setting Partnership. Hernandez-Martin A, Davila-Seijo P, de Lucas R, Baselga E, Redondo P, Martin-Santiago A, Azana-Defez JM, Gonzalez-Viejo I, Jimenez-Ferreres L, Gonzalez-Ensenat MA, Arroyo-Manzanal MI, Soria JM, Garcia-Doval I. Br J Dermatol 2015; 173: 1280-3.
  • Research unit of the Spanish Academy of Dermatology and Venerology Foundation. Garcia-Doval I. Actas Dermosifiliogr 2015; 106: 346-9.
  • Current dystrophic epidermolysis bullosa research does not match research needs perceived by patients and clinicians. Davila-Seijo P, Hernandez-Martin A, Morcillo-Makow E, Rajan C, Garcia-Doval I. J Am Acad Dermatol 2014; 71: 1008-11.
  • Prevalence of dystrophic epidermolysis bullosa in Spain: a population-based study using the 3-source capture-recapture method. Evidence of a need for improvement in care. Hernandez-Martin A, Aranegui B, Escamez MJ, de Lucas R, Vicente A, Rodriguez-Diaz E, Bernabeu-Wittel J, Gonzalez-Hermosa R, Garcia-Patos V, Ginarte M, Mascaro JM, Jr., Corredera C, Baselga E, Santiago JL, Chaves A, Roman C, Evole M, Martin-Santiago A, Torrelo A, Del Rio M, Feito M, Gonzalez-Ensenat MA, Romero G, Morcillo-Makow E, Abaitua I, Garcia-Doval I. Actas Dermosifiliogr 2013; 104: 890-6.
  • Prioritization of therapy uncertainties in Dystrophic Epidermolysis Bullosa: where should research direct to? an example of priority setting partnership in very rare disorders. Davila-Seijo P, Hernandez-Martin A, Morcillo-Makow E, de Lucas R, Dominguez E, Romero N, Monros E, Feito M, Carretero L, Aranegui B, Garcia-Doval I. Orphanet J Rare Dis 2013; 8: 61.
  • Prevalence of autosomal recessive congenital ichthyosis: a population-based study using the capture-recapture method in Spain. Hernandez-Martin A, Garcia-Doval I, Aranegui B, de Unamuno P, Rodriguez-Pazos L, Gonzalez-Ensenat MA, Vicente A, Martin-Santiago A, Garcia-Bravo B, Feito M, Baselga E, Ciria S, de Lucas R, Ginarte M, Gonzalez-Sarmiento R, Torrelo A. J Am Acad Dermatol 2012; 67: 240-4.

Publicaciones resultantes de asesorías a la UI.